Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03845881 · ClinicalTrials.gov registry record · Early Phase 1

Trial Comparing a Multi-Modal Pain Protocol With and Without Opioids Following Total Joint Arthroplasty

A Early Phase 1 study, sponsored by Mayo Clinic.

Completed
Registry status
Early Phase 1
Development phase
45
Enrollment target

NCT03845881: Completed Early Phase 1 study, sponsored by Mayo Clinic.

NCT03845881 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03845881, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Early Phase 1
Development phase
45 participants
Enrollment target

Study Summary

To help curb the use of opioid medications following orthopedic surgery investigators have developed a new multi-modal pain pathway. Investigators aim to compare this regimen with and without the inclusion of opioid medications. This study will be performed in a randomized, double-blinded, placebo-controlled fashion in patients undergoing primary total knee or total hip arthroplasty. Investigators hypothesize that the opioid devoid pathway will show equivalent pain scores to the pathway that includes opioids while also having less constipation, nausea, and vomiting following surgery. If successful, this would create a dramatic decrease in opioid consumption following orthopedic surgery while still providing appropriate pain relief to patients.

Interventions

  • DRUG Oxycodone
  • DRUG Placebo Oral Tablet

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2019-04-10
Est. Completion 2020-07-28
Phase Early Phase 1

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03845881

The ClinicalTrials.gov registry entry for NCT03845881 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Oxycodone is the first listed.

NCT03845881 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03845881 about?

NCT03845881 is a clinical study titled "Trial Comparing a Multi-Modal Pain Protocol With and Without Opioids Following Total Joint Arthroplasty". To help curb the use of opioid medications following orthopedic surgery investigators have developed a new multi-modal pain pathway. Investigators aim to compare this regimen with and without the inclusion of opioid medications. This study will be performed in a randomized, double-blinded, placebo-c...

What is the current status of trial NCT03845881?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2019-04-10. Estimated completion is 2020-07-28.

What interventions are being tested in trial NCT03845881?

The interventions under investigation include: Oxycodone (DRUG), Placebo Oral Tablet (DRUG).

Who is sponsoring clinical trial NCT03845881?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.